Literature DB >> 4937134

Use and control of cephalosporins.

S Eykyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4937134      PMCID： PMC477020          DOI： 10.1136/jcp.24.5.419

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  18 in total

1.  Oliguria following transplantation of kidneys donated by blood relatives.

Authors:  J G Turcotte; T J Herrmann; O Haig; C O'Dell; J Cerny; J A Greene
Journal:  Surg Gynecol Obstet       Date:  1970-01

2.  Acute toxicity of cephaloridine, an antibiotic derived from cephalosporin C.

Authors:  R M Atkinson; J P Currie; B Davis; D A Pratt; H M Sharpe; E G Tomich
Journal:  Toxicol Appl Pharmacol       Date:  1966-05       Impact factor: 4.219

3.  Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity.

Authors:  R L Perkins; M A Apicella; I S Lee; F E Cuppage; S Saslaw
Journal:  J Lab Clin Med       Date:  1968-01

4.  Treatment of bacterial endocarditis with cephalothin.

Authors:  J J Rahal; B R Meyers; L Weinstein
Journal:  N Engl J Med       Date:  1968-12-12       Impact factor: 91.245

5.  Cephalexin therapy as related to renal function.

Authors:  S A Kabins; B Kelner; E Walton; E Goldstein
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

6.  Coombs' positive reactions associated with sodium cephalothin therapy.

Authors:  H R Gralnick; L D Wright; M H McGinniss
Journal:  JAMA       Date:  1967-03-06       Impact factor: 56.272

7.  Laboratory and clinical experience with cephalexin.

Authors:  A C Kind; D G Kestle; H C Standiford; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

8.  Development of staphylococci cross-resistant to cephalexin and methicillin.

Authors:  A C Kind; D G Kestle; H C Standiford; P Freeman; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

9.  Positive direct Coombs tests due to cephalothin.

Authors:  L Molthan; M M Reidenberg; M F Eichman
Journal:  N Engl J Med       Date:  1967-07-20       Impact factor: 91.245

10.  Subacute toxicity of cephaloridine to various species.

Authors:  R M Atkinson; J D Caisey; J P Currie; T R Middleton; D A Pratt; H M Sharpe; E G Tomich
Journal:  Toxicol Appl Pharmacol       Date:  1966-05       Impact factor: 4.219
View more
  9 in total

1.  Response of ampicillin resistant Escherichia coli to cephalosporins in an in vitro model simulating conditions of bacterial growth in the urinary bladder.

Authors:  D Greenwood; F O'Grady
Journal:  Br J Exp Pathol       Date:  1975-04

Review 2.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Activity of cefazolin against dense populations of enterobacteria.

Authors:  D Greenwood; C H Chan-Teoh; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

Review 4.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  New antibacterial drugs.

Authors: 
Journal:  Br Med J       Date:  1971-10-16

6.  Dual-action cephalosporin utilizing a novel therapeutic principle.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

7.  Identification of cephalosporin-resistant Staphylococcus aureus with the disc diffusion method.

Authors:  H O Hallander; G Laurell
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

8.  Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.

Authors:  G J Miraglia; K J Renz; H H Gadebusch
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

9.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.